lung cancer-related insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Continuous insomnia related to lung cancer treatment or cancer itself for at least 3 months, and meets the diagnostic criteria of chronic insomnia according to The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), American Psychiatric Association (APA); (2) Diagnosed with stage I-IIIA pulmonary malignancy according to imaging result, histologic examination and TNM classification; (3) An Eastern Cooperation Oncology Group (ECOG) performance status of less than 2; (4) Score of Pittsburgh Sleep Quality Index (PSQI) of more than 11; (5) Male or female patients aged between 19 to 70 years old; (6) Have never received acupuncture treatment; (7) Willing to participate in the trial and provide written consent.
Exclusion criteria
Exclusion criteria: (1) A plan for surgery and chemotherapy during the trial; (2) A diagnosis of secondary insomnia caused by depression, anxiety or other psychiatric disorders and addition of caffeine, alcohol or drugs; (3) Index of cancer pain measured by the numeric rating scale >= 4; (4) A diagnosis of severe cognitive deficit failing to cooperate; (5) A diagnosis of severe diseases of the cardiovascular, hepatic, renal, cerebrovascular, or hematopoietic systems; (6) Acupuncture area with skin infection, ulcer and soars; (7) Pregnant or breastfeeding women; (8) Having participated in other clinic trials within 4 weeks of the beginning of this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index (PSQI); | — |
Secondary
| Measure | Time frame |
|---|---|
| wActiSleep-BT wireless sleep monitor;Quality of Life Questionnaire Core-30;Patient Health Questionnaire-9; | — |
Countries
China
Contacts
Shanghai Municipal Hospital of Traditional Chinese Medicine